Testing the LILAC method for lipoprotein(a) education
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a new method called LILAC to help people learn about and manage high levels of lipoprotein(a), a type of fat in the blood. It is for anyone 16 or older who attends educational events or is part of a health group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 16 years old or older.
- You are a student or participant at a higher learning institute, or you attend educational talks by Dr. Loh.
- You are a patient or member of the public attending a lipid awareness event.
- You are in a patient support group or advocacy network.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This is a registry study that looks at how common high lipoprotein(a) levels are. It helps researchers understand this condition better.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
This study looks at a blood marker called Lp(a) in adults who have lymphedema. The goal is to understand whether checking Lp(a) is important for people with this condition.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.